Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection?
- PMID: 33515615
- PMCID: PMC7839803
- DOI: 10.1016/j.ijcard.2021.01.019
Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection?
Conflict of interest statement
Declaration of Competing Interest Dr. Tamargo reports no conflicts of interest.
Comment on
-
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.Int J Cardiol. 2021 Apr 15;329:266-269. doi: 10.1016/j.ijcard.2020.12.024. Epub 2020 Dec 11. Int J Cardiol. 2021. PMID: 33309764 Free PMC article.
References
-
- Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., et al. for the Global COVID-19 Thrombosis Collaborative Group COVID-19 and thrombotic or thromboembolic disease implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2020;75:2950–2973. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
